ArticleDrug design, development and therapy2025

Tempol Mitigates Methotrexate-Induced Osteotoxicity via Oxidative Stress Modulation and MAPK Pathway Inhibition.

Fariz Selimli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.